Your browser doesn't support javascript.
loading
[Hematological side effects of natalizumab: Correlation with clinical outcome]. / Anomalies hématologiques du natalizumab et sa signification clinique.
Bresch, S; Cohen, M; Rocher, F; Laffon, M; Thomas, P; Lebrun, C.
Affiliation
  • Bresch S; Service de neurologie, hôpital Pasteur, 30, voie Romaine, BP 69, 06002 Nice cedex, France. Saskia.bresch@yahoo.fr
Rev Neurol (Paris) ; 168(2): 116-20, 2012 Feb.
Article in Fr | MEDLINE | ID: mdl-22100322
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Antibodies, Monoclonal, Humanized / Hematologic Diseases Type of study: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Fr Journal: Rev Neurol (Paris) Year: 2012 Document type: Article Affiliation country: France Country of publication: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Antibodies, Monoclonal, Humanized / Hematologic Diseases Type of study: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Fr Journal: Rev Neurol (Paris) Year: 2012 Document type: Article Affiliation country: France Country of publication: France